Related Party Transactions - Revenue Recognition (Details) - Janssen Pharmaceuticals Inc - Asset Purchase Agreement $ in Thousands |
6 Months Ended |
|---|---|
|
Jun. 30, 2024
USD ($)
| |
| Related Party Transaction [Line Items] | |
| Deferred revenue at the beginning | $ 36,943 |
| Milestone payment allocated to performance obligations | 20,982 |
| Deferred revenue recognized as service revenue during the three-month period | (979) |
| Effects of exchange rate changes | 315 |
| Deferred revenue at the end | $ 57,261 |
| X | ||||||||||
- Definition The effect of exchange rates on customer contract liability. No definition available.
|
| X | ||||||||||
- Definition The amount of milestone payment received. No definition available.
|
| X | ||||||||||
- Definition Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due. No definition available.
|
| X | ||||||||||
- Definition Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|